This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stamme, C. Articles by Seydel, U. Search for Related Content PubMed PubMed Citation Articles by Stamme, C. Articles by Seydel, U.

Surfactant Protein A Inhibits Lipopolysaccharide-Induced Immune Cell Activation by Preventing the Interaction of Lipopolysaccharide with Lipopolysaccharide-Binding Protein

Department of Immunochemistry and Biochemical Microbiology, Research Center Borstel, Center for Medicine and Bioscience, Borstel; Department of Anesthesiology, University Hospital Lübeck, Lübeck; Department of Immunology and Cell Biology, Research Center Borstel, Borstel; and Department of Microbiology and Hygiene, Charité Medical Center, Humboldt University Berlin, Berlin, Germany

Address correspondence to: Dr. Cordula Stamme, Dept. of Immunochemistry and Biochemical Microbiology, Research Center Borstel, Parkallee 22, 23845 Borstel, Germany. E-mail: cstamme{at}fz-borstel.de

Pulmonary surfactant protein (SP)-A, an innate immune molecule, modifies lipopolysaccharide (LPS)-induced cell responses. Because SP-A avidly binds to the deep rough (Re) mutant of LPS, we first investigated the functional consequences of this interaction and found that preincubation of Re-LPS with SP-A significantly and in a dose-dependent manner decreased the sensitivity of rat alveolar macrophages and human mononuclear cells to Re-LPS–induced activation at limited amounts of LPS-binding protein (LBP). At high LBP concentrations, the SP-A–mediated cellular inhibition of Re-LPS–induced activation was abrogated. Because LBP-catalyzed binding of LPS to CD14 is essential for low-dose LPS-induced signaling, we then hypothesized that SP-A inhibits Re-LPS–induced immune cell activation via inhibiting the binding of Re-LPS to LBP. Binding competition experiments employing a surface plasmon resonance technique showed that Re-LPS preincubated with SP-A bound to LBP to a significantly lesser extent than Re-LPS alone. For enhanced cellular association of [³H]LPS/SP-A complexes to occur, the expression of membrane-bound CD14 by human embryonic kidney cells 293 was not essential. Therefore, the ability of SP-A to inhibit immune cell activation by Re-LPS may be due to its ability to block the binding of Re-LPS to LBP and prevent the initiation of the LBP/CD14 pathway for inflammatory reactions in the lung.

Abbreviations: Dulbecco's modified Eagle's medium, DMEM • Dulbecco's phosphate-buffered saline, DPBS • electrophoretic mobility shift assay, EMSA • fetal calf serum, FCS • human embryonic kidney, HEK • lipopolysaccharide, LPS • LPS-binding protein, LBP • membrane-bound CD14, mCD14 • nuclear factor B, NF-B • phosphatidylserine, PS • Rb mutant of Escherichia coli strain LCD 25 LPS, Rb-LPS • Re mutant of Escherichia coli strain F515, Re-LPS • recombinant human, rh • soluble CD14, sCD14 • surfactant protein, SP • surface plasmon resonance, SPR • tumor necrosis factor, TNF

This article has been cited by other articles:

				Z.-Q. Wang, W.-M. Xing, H.-H. Fan, K.-S. Wang, H.-K. Zhang, Q.-W. Wang, J. Qi, H.-M. Yang, J. Yang, Y.-N. Ren, et al. The Novel Lipopolysaccharide-Binding Protein CRISPLD2 Is a Critical Serum Protein to Regulate Endotoxin Function J. Immunol., November 15, 2009; 183(10): 6646 - 6656. [Abstract] [Full Text] [PDF]

				C. Moulakakis and C. Stamme Role of clathrin-mediated endocytosis of surfactant protein A by alveolar macrophages in intracellular signaling Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L430 - L441. [Abstract] [Full Text] [PDF]

				I. Garcia-Verdugo, E. Garcia de Paco, Q. Espinassous, A. Gonzalez-Horta, M. Synguelakis, J. Kanellopoulos, L. Rivas, R. Chaby, and J. Perez-Gil Synthetic peptides representing the N-terminal segment of surfactant protein C modulate LPS-stimulated TNF-{alpha} production by macrophages Innate Immunity, February 1, 2009; 15(1): 53 - 62. [Abstract] [PDF]

				T. Meier, A. Lange, H. Papenberg, M. Ziemann, C. Fentrop, U. Uhlig, P. Schmucker, S. Uhlig, and C. Stamme Pulmonary Cytokine Responses During Mechanical Ventilation of Noninjured Lungs With and Without End-Expiratory Pressure Anesth. Analg., October 1, 2008; 107(4): 1265 - 1275. [Abstract] [Full Text] [PDF]

				I. Garcia-Verdugo, Z. Tanfin, E. Dallot, M.-J. Leroy, and M. Breuiller-Fouche Surfactant Protein A Signaling Pathways in Human Uterine Smooth Muscle Cells Biol Reprod, August 1, 2008; 79(2): 348 - 355. [Abstract] [Full Text] [PDF]

				C. Moulakakis, S. Adam, U. Seitzer, A. B. Schromm, M. Leitges, and C. Stamme Surfactant Protein A Activation of Atypical Protein Kinase C {zeta} in I{kappa}B-{alpha}-Dependent Anti-Inflammatory Immune Regulation J. Immunol., October 1, 2007; 179(7): 4480 - 4491. [Abstract] [Full Text] [PDF]

				A. M. Pastva, J. R. Wright, and K. L. Williams Immunomodulatory Roles of Surfactant Proteins A and D: Implications in Lung Disease Proceedings of the ATS, July 1, 2007; 4(3): 252 - 257. [Abstract] [Full Text] [PDF]

				M. Papavlassopoulos, C. Stamme, L. Thon, D. Adam, D. Hillemann, U. Seydel, and A. B. Schromm MaxiK Blockade Selectively Inhibits the Lipopolysaccharide-Induced I{kappa}B-{alpha}/NF-{kappa}B Signaling Pathway in Macrophages J. Immunol., September 15, 2006; 177(6): 4086 - 4093. [Abstract] [Full Text] [PDF]

				C. Yamada, H. Sano, T. Shimizu, H. Mitsuzawa, C. Nishitani, T. Himi, and Y. Kuroki Surfactant Protein A Directly Interacts with TLR4 and MD-2 and Regulates Inflammatory Cellular Response: IMPORTANCE OF SUPRATRIMERIC OLIGOMERIZATION J. Biol. Chem., August 4, 2006; 281(31): 21771 - 21780. [Abstract] [Full Text] [PDF]

				S. Knapp, S. Florquin, D. T. Golenbock, and T. van der Poll Pulmonary Lipopolysaccharide (LPS)-Binding Protein Inhibits the LPS-Induced Lung Inflammation In Vivo. J. Immunol., March 1, 2006; 176(5): 3189 - 3195. [Abstract] [Full Text] [PDF]

				F. Sanchez-Barbero, J. Strassner, R. Garcia-Canero, W. Steinhilber, and C. Casals Role of the Degree of Oligomerization in the Structure and Function of Human Surfactant Protein A J. Biol. Chem., March 4, 2005; 280(9): 7659 - 7670. [Abstract] [Full Text] [PDF]

				Y. Wu, S. Adam, L. Hamann, H. Heine, A. J. Ulmer, U. Buwitt-Beckmann, and C. Stamme Accumulation of Inhibitory {kappa}B-{alpha} as a Mechanism Contributing to the Anti-Inflammatory Effects of Surfactant Protein-A Am. J. Respir. Cell Mol. Biol., December 1, 2004; 31(6): 587 - 594. [Abstract] [Full Text] [PDF]

				A. Oshiro, H. Otani, Y. Yagi, S. Fukuhara, and C. Inagaki Protease-Activated Receptor-2-Mediated Inhibition for Ca2+ Response to Lipopolysaccharide in Guinea Pig Tracheal Epithelial Cells Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 886 - 892. [Abstract] [Full Text] [PDF]

				J. F. Alcorn and J. R. Wright Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L129 - L136. [Abstract] [Full Text] [PDF]

				C. L. S. George, M. L. White, M. E. O'Neill, P. S. Thorne, D. A. Schwartz, and J. M. Snyder Altered surfactant protein A gene expression and protein metabolism associated with repeat exposure to inhaled endotoxin Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1337 - L1344. [Abstract] [Full Text] [PDF]

				C. Casals, J. Arias-Diaz, F. Valino, A. Saenz, C. Garcia, J. L. Balibrea, and E. Vara Surfactant strengthens the inhibitory effect of C-reactive protein on human lung macrophage cytokine release Am J Physiol Lung Cell Mol Physiol, March 1, 2003; 284(3): L466 - L472. [Abstract] [Full Text] [PDF]